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Abstract 
The cyanobacteria are known to be a rich source of metabolites with a variety of biological activities in 
different biological systems. In the present work, the bioactivity of aqueous and organic (methanolic and 
hexane) crude extracts of cyanobacteria isolated from estuarine ecosystems was studied using different 
bioassays. The assessment of DNA damage on the SOS gene repair region of mutant PQ37 strain of 
Escherichia coli was performed. Antiviral activity was evaluated against influenza virus, HRV-2, CVB3 
and HSV-1 viruses using crystal violet dye uptake on HeLa, MDCK and GMK cell lines. Cytotoxicity 
evaluation was performed with L929 fibroblasts by MTT assay. Of a total of 18 cyanobacterial isolates 
studied, only the crude methanolic extract of LEGE 06078 proved to be genotoxic (IF > 1.5) in a dose-
dependent manner and other four were putative candidates to induce DNA damage. Furthermore, the crude 
aqueous extract of LEGE 07085 showed anti- herpes type 1 activity (IC50 = 174.10 μg dry extract mL−1) 
while not presenting any cytotoxic activity against GMK cell lines. Of the 54 cyanobacterial extracts tested, 
only the crude methanolic and hexane ones showed impair on metabolic activity of L929 fibroblasts after 
long exposure (48–72 h). The inhibition of HSV-1 and the strong cytotoxicity against L929 cells observed 
emphasizes the importance of evaluating the impact of those estuarine cyanobacteria on aquatic ecosystem 
and on human health. The data also point out their potential application in HSV-1 treatment and 
pharmacological interest. 
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1. Introduction 
Cyanobacteria are prokaryotic oxygenic photoautotroph organisms found in all kind of habitats. They are 
known worldwide for their ability to produce several types of toxins such as neurotoxins and hepatotoxins 
(Carmichael, 1994). However, on the last decades cyanobacteria have been also identified as a new and 
prolific source of bioactive compounds (Abed et al., 2009). The bioactive compounds produced include 
polyketides, amides, alkaloids, fatty acids, indoles and lipopeptides (Burja et al., 2001 and Patterson et al., 
1994). Diverse biological activities have been surveyed and reported, ranging from antiviral, antialgal, 
antibacterial, antifungal to antitumour activity (Abed et al., 2009 and Bubik et al., 2008). 
Previous studies have shown that the cyanotoxins and cyanobacterial extracts can be genotoxic and 
mutagenic, either with or without metabolic activation, but little information is available (Ding et al., 1999, 
Mankiewicz et al., 2002, Shen et al., 2002 and Zhan et al., 2004). Moreover, antiviral as well as cytotoxic 
activity of cyanobacterial extracts has been previously reported. Cyanobacteria belonging to the genera 
Calothrix, Microcystis, Nodularia, Nostoc, Spirulina, Oscillatoria and Scytonema have been described as 
producers of compounds with broad-spectrum antiviral properties. The inhibitory concentration (IC50) of 
antiviral activity can range between 0.37 and 300.0 μg extract/ml. Spirulan-like substances, 
polysaccharides, carbohydrates and peptidic compounds have been reported as antiviral compounds against 
herpesviruses, paramyxoviruses, influenza viruses and human immunodeficiency virus type 1. 
Cyanobacteria have been also reported to cause cytotoxicity by induced apoptosis in mammalian cell lines 
as the human leukemia cell line, and fish cell lines (Hernandez-Corona et al., 2002, Kanekiyo et al., 2007, 
Mundt et al., 1997, Nowotny et al., 1997, Patterson et al., 1993, Rechter et al., 2006, Surakka et al., 2005, 
Teneva et al., 2003 and Zainuddin et al., 2002). 
 The cyanobacteria ability to produce toxins as well as bioactive secondary metabolites makes these 
organisms potentially hazardous to aquatic ecosystem and to human health (Carmichael, 
2001 and Martins et al., 2008). While toxicity of fresh and marine waters cyanobacterial 
metabolites has been well documented in vitro and in vivo, few surveys about the bioactivity of 
estuarine cyanobacteria have been published. Ecotoxicological effects of cyanobacteria of 
freshwaters and marine biotopes on animals, plants and humans have been reported. Toxigenicity 
has been mainly linked to the genera Anabaena, Anabaenopsis, Hapalosiphon, Lyngbya, 
Microcystis, Nostoc, Synechoccocus and Planktothrix. Neurotoxic and hepatotoxic effects as well 
antialgal, immunosuppressive, antimycotic, antibacterial, antitumour and antiviral activity have 
been described ( Gademann and Portmann, 2008, Hirata et al., 2003, Jaiswal et al., 2008, Martins 
et al., 2007, Martins et al., 2008, Mundt et al., 2001 and Wiegand and Pflugmacher, 2005). On the 
other hand, recent studies have already demonstrated that cyanobacteria isolated from estuaries 
induce toxic effects on marine invertebrates ( Lopes et al., 2010). 
 Considering the potential bioactivity of cyanobacteria from estuarine habitats, an assessment of 
genotoxicity, cytotoxic and antiviral activity of cyanobacteria was done. A battery of four in vitro 
assays was applied to assess specific potential biological activity. The DNA damage was evaluated 
using the SOS-Chromotest based on the induction of SOS-repair system of the strain Escherichia 
coli PQ 37 ( Quillardet et al., 1982). The screening of antiviral activity was done by the evaluation 
of cytopathic effect using crystal violet dye uptake against coxsackie virus B3 strain, the influenza 
virus A strain Hong Kong/68, the herpes simplex virus type 1 strain and rhinovirus ( Schmidtke et 
al., 2001). Cytotoxicity evaluation was also performed with L929 cell lines by MTT assay ( 
Berridge and Tan, 1993, Freshney, 2000 and Li and Song, 2007). 
 2. Material and methods 
 2.1. Cyanobacterial cultures 
 The sampling was performed during the low tide from both benthos and plankton on estuarine 
systems of North and Centre of Portugal specifically, Minho, Douro and Vouga (42° 15′ to 40° 
15′ north latitude and 8° 54′ to 8° 38′ west longitude). Eighteen cyanobacterial strains were 
isolated, belonging to six genera Cyanobium, Leptolyngbya, Microcoleus, Nodularia, Nostoc and 
Synechocystis (see Table 1). Isolation and culture were performed in Z8 medium ( Kotai, 1972) 
supplemented with 10–35 mg NaCl ml−1 (P.A. Sigma–Aldrich®, Germany) and at 25 °C, light 
intensity of 20.8–27.4 × 10−6 E m−2 s−1 with a light/dark cycle of 14/10 h. All the cultures were 
unicyanobacterial and non-axenic but no visible bacterial contamination was present in any of the 
cultures. Cultures of the isolates at the exponential growth phase were collected by centrifugation 
or filtration and washed with bidistilled water, frozen at −20 °C and then freeze-dried. 
 
 2.2. Cyanobacterial extracts 
The freeze-dried cells were extracted with 70% methanol (1 ml per 25 mg dw) with an ultrasonic probe 
Vibra cell50 (Sonics & Materials Inc., Danbury, USA) at 4 °C during 3 × 20 s, centrifuged at 9300g during 
10 min and evaporated. The obtained residue was resuspended in sterile 0.85% saline solution with 10% 
DMSO (AldraSorb™ 99.8% Sigma–Aldrich®, Germany) and used for the genotoxic trial. Regarding the 
cytotoxic and cytophatic effect assays, a similar procedure was used with slight modifications. Three 
solvents with increasing polarity were applied, n-hexane (P.A. Merck, Germany), methanol (P.A. Merck, 
Germany) and bidistilled water. The obtained residues were resuspended in the same solvent used for the 
extraction, except for the hexane which was replaced by 1% DMSO (AldraSorb™ 99.8% Sigma–Aldrich®, 
Germany). 
2.3. DNA damage assay 
The genotoxic activity was assessed by the SOS Chromotest kit version 6.3 (EBIP, Canada) based on a 
bacterial colorimetric assay developed by Quillardet and Hofnung (1993) and Quillardet et al. (1982). In 
brief, it was used a strain of Escherichia coli genetically modified in which the SOS gene promoter has 
been linked to the Lac Z gene. DNA damage was evaluated by measuring the absorbance of beta-
galactosidase (ß-gal) at 615 nm using a PowerWave™ Microplate Spectrophotometer (BioTek, USA). 
Since the analysis and synthesis of the ß-gal enzyme it is dependent upon the viability of bacteria, ATP 
activity was also tested using alkaline phosphatase (PAL) measuring its absorbance at 405 nm. A standard 
genotoxic solution was used containing 10 μg mL−1 of 4NQO in 10% DMSO saline. Six twofold dilutions 
from 0.78 to 25.00 mg mL−1 of the cyanobacterial extracts in 10% DMSO saline solution were analyzed in 
triplicate. The data obtained were expressed as induction factor (IF) defined as (B-galc/PALc)/(B-hal0/PAL0), 
where 0 represents the negative control (sterile ultrapure water) and c concentration of the sample. 
2.4. Cytotoxicity assays 
L929 cell lines (ATCC CCL-1™) were cultured in α-MEM (Gibco, Invitrogen No. 11900-073) 
supplemented with 10% (v/v) fetal bovine serum (Gibco Invitrogen No. 10106-169), 1% penicillin and 
streptomycin solution (Gibco Invitrogen No. 15140-122) and 2.5 μg mL−1 of fungizone (Gibco Invitrogen 
No. 15290-026). Cells were seeded at 3 × 103 cells per well (96-well culture plates) and exposed to the 
extracts for 24, 48 and 72 h. Cytotoxicity of the extracts was evaluated by the 3-(4, 5-dimethylthiazole-2-
yl)-2, 5-diphenyltetrazolium bromide (MTT) assay. 
Cultures were maintained at 37 °C in a humidified incubator with 5% CO2 atmosphere for the incubation 
times mentioned above, without any medium change. The MTT assay was carried out according to Berridge 
and Tan (1993). Cultures were exposed to the extracts for 24, 48 and 72 h. At the end of each testing time, 
the culture supernatants were removed and MTT solution (0.5 mg mL−1) was added to each well and the 
plates were incubated for 4 h at 37 °C. The MTT solution was removed and DMSO was added to dissolve 
formazan crystals. The absorbance at 550 nm was read on a PowerWave™ Microplate Spectrophotometer 
(BioTek, USA). The percentage of viability was calculated as (AT/AC)∗100, where AT and AC are the 
optical densities of treated and control cells, respectively. 
2.5. Antiviral activity 
HeLa Ohio (human cervix carcinoma; ATCC CCL-2™), GMK (green monkey kidney cells; Schaper and 
Brümmer, Salzgitter, Germany), and Madin-Darby canine kidney (MDCK) cells (Friedrich-Loeffler 
Institute, Riems, Germany) were used in the antiviral trials. The HeLa Ohio cells were grown in MEM/E 
medium (SIGMA No. M-0643), and the GMK and MDCK cells in Dulbecco’s modified MEM/E (SIGMA 
No. D-7777) supplemented with 10% NCS (HeLa Ohio; Greiner No. 758010, Germany) or 10% FBS 
(GMK and MDCK; Greiner No. 758075, Germany), 100 U/ml penicillin as well as streptomycin (CCpro 
No. Z-13-M, Germany). The test medium used for the anti-coxsackie virus B3 and anti-herpes simplex 
virus type 1 tests contained only 2% of the appropriate serum. The medium applied in the anti-influenza 
virus-A assays was formulated with 3 μg ml−1 trypsin and did not contain serum. All cells were proved to 
be free of mycoplasma contamination before using. Cultures were maintained at 37 °C in a humidified 
incubator with 5% CO2 atmosphere. 
2.5.1. Viruses 
Virus stocks of the coxsackie-virus B3 strain Nancy (CVB3; Institute of Poliomyelitis and Virus 
Encephalitides, Moscow, Russia), the influenza virus A/Hong Kong/68 (influenza virus; Schaper and 
Brümmer, Salzgitter, Germany), the herpes simplex virus type 1 strain Kupka (HSV-1; own strain 
collection) and rhinovirus type 2 (HRV-2; Institute of Virology, Vienna, Austria) were prepared in HeLa 
Ohio (CVB3 and HRV-2), MDCK (Influenza virus), and GMK cells (HSV-1). The titre of virus stocks was 
previously determined by plaque assay on the respective cell monolayer. 
2.5.2. Cytopathic effect (CPE) inhibitory assay 
The in vitro assay of anti-viral activity was performed applying the protocol of Schmidtke et al. (2001) and 
Makarov et al. (2005). Briefly, the CPE assay is based on the lysis of HeLa Ohio, MDCK, and GMK cells 
by CVB3 and HRV-2, influenza virus, and HSV-1 K1, respectively. The antiviral evaluation was carried 
out in 1-day-old semi confluent (HRV-2) or 2-day-old confluent (CVB3, influenza virus, and HSV-1) 
monolayers of the mentioned cell lines growing in 96-well flat-bottomed microtiter plates (Falcon 3075). 
After removal of the culture medium, 50 μl of extract solution or medium (cell and control virus) and a 
constant amount of virus in a volume of 50 μl (0.1 multiplicity of infection for CVB3 and influenza virus, 
0.01 multiplicity of infection for HRV-2) or medium (cell control) were added to the cells. Six wells of 
non-infected and six wells of infected cells without the test extract were used as cell and virus control, 
respectively, on each plate. To calibrate the assay, the 50% and 100% plaque inhibitory concentrations of 
reference compounds (each three wells; guanidine hydrochloride for CVB3, pleconaril for HRV-2, 
amantadine for influenza virus, and foscarnet for HSV-1) were included as positive control in each 
microtiter plate. Plates were incubated for 24 h (CVB3 and influenza virus), 48 h HSV-1, or 72 h (HRV2) 
at 37 °C in a humidified atmosphere with 5% CO2. At this time a complete cytopathic effect was observed 
microscopically in virus control wells. The cells were fixed and stained with crystal violet formalin solution. 
After dye extraction, the optical density of individual wells was quantified at 550/630 nm with a microplate 
reader. The percentage of antiviral activities of the tests extracts were calculated by ((mean OD of six cell 
controls-mean OD of six virus controls)/(mean OD of test extract-mean OD of six virus controls)) × 100. 
The 50% CPE inhibitory dose (IC50) was calculated. 
2.5.3. Cytotoxicity 
The cytotoxicity measurement by the crystal violet dye assay was made simultaneously with the antiviral 
activity evaluation to guarantee that the potential virus-specific compound or mixture should have low or 
no effects on cellular metabolism and thus showing none toxicity against the host organism. The 50% 
cytotoxic concentration (CC50) of the cyanobacterial extracts was determined on 2-day-old confluent HeLa 
Ohio, MDCK and GMK cell monolayers grown in the internal 60 wells of 96-well tissue culture plates 
(Falcon 3075) as described by Schmidtke et al. (2001). Briefly, cell monolayers were incubated with eight 
twofold serial dilutions of compounds for 72 h (37 °C, 5% CO2). Then, the cells were fixed and stained 
with a crystal violet formalin solution. After dye extraction, the optical density of individual wells was 
quantified at 550/630 nm with a microplate reader. Cell viability of individual compound-treated wells was 
evaluated as the percentage of the mean value of optical density resulting from six mock-treated cell 
controls which was set 100%. The CC50 was defined as the compound concentration reducing the viability 
of untreated cell cultures by 50%. It was calculated from the logarithmic regression curves. 
2.6. Chemical analysis – MALDI TOF-MS 
Lyophilised samples of the cyanobacterial cultures, which showed bioactivity, were screened for common 
cyanotoxins and other peptides by MALDI-TOF MS. The procedure and conditions can be seen in Lopes 
et al. (2010). 
2.7. Statistical analyses 
Data were expressed as means ± standard deviation (SD). Significant differences were determined by one-
way analysis of variance (ANOVA) at p < 0.05. The goodness of fit of the data to normal distribution was 
tested applying the Kolmogorov–Smirnov statistic. The statistical analysis was performed with SPSS 
software (version 17.0, USA). When the normality and homoscedasticity assumptions were not met, a non-
parametric Kolmogorov–Smirnov test for two- independent samples was applied. A significant level of 
p < 0.05 was accepted. The CC50, defined as the concentration that caused 50% maximum cytotoxic effect, 
was calculated by regression analysis of the dose–response curves for MTT and crystal violet assay. 
3. Results 
The genotoxic effects of the 18 extracts analyzed were evaluated using crude methanolic 70% (v/v) extracts, 
without metabolic activation and were expressed through its induction factors (IF). As shown in Table 2, 
LEGE 06078 showed genotoxic effects, presenting IF values higher than 1.5 and increasing significantly 
(p < 0.05) in a dose-dependent manner. The LEGE 06078 extract belongs to the Phormidium genus. 
Furthermore, 22% of the cyanobacterial extracts were potentially genotoxic since at least one of the two 
parameters evaluated, IF higher than 1.5 and response in a dose-dependent manner, were not verified. Some 
isolates showed an IF higher than 1.5 from a concentration of 6.25 mg mL−1 but not enough to consider 
genotoxic. It could be an artifact resulting of a high dose. These candidates belong mainly to Oscillatoriales, 
the exception being LEGE 06077, which belongs to Nostocales. The remaining isolates have no 
genotoxicity since the IF values were above 1.0 (not shown), independently of the concentration value. 
  
  
Cytotoxic effects of cyanobacterial crude extracts were analyzed in L929 mouse fibroblasts by MTT assay 
performed in cultures exposed for 24, 48 and 72 h. Generally, the extracts were found to be toxic against 
L929 cell lines. Although no signals of cytotoxicity at 24 h-exposure time were observed for L929 cells, 
marked cytotoxicity was observed with crude hexane and methanolic extracts for higher exposure times 
(48 and 72 h). 
The analysis of the 54 cyanobacterial extracts revealed 23 extracts with marked cytotoxicity activity at 72 h. 
The observed cytotoxicity of the extracts against L929 cell line, at 72 h incubation, expressed as cell 
viability percentage, is shown in Table 3. The aqueous extracts did not induce any cytotoxic effects on 
L929 cell line contrarily to the methanolic and n-hexane extracts. The methanolic extracts caused 15–85% 
loss of cell viability of L929 cells. From a total of 18 methanolic extracts, 12 caused moderate to potent 
cytotoxic effects, causing 15–50% inhibition of the cell viability of L929 cell line at 200.0 μg DW mL−1. 
The occurrence of highest cytotoxicity (15–30%) was observed for the LEGE06077, 07073 and 07083 
methanolic extracts which belong to the Nostocales and Chroococcales order, respectively. The n-hexane 
extracts did induce moderate cytotoxicity ranging from 30% to 70% of cell viability at the highest 
concentration of 200.0 μg DW mL−1. From the 18 n-hexane extracts, 11 caused 50% of growth inhibition 
of L929 cell line at 200.0 μg DW mL−1. These extracts fit mainly in the Oscillatoriales group similarly to 
methanolic extracts. Concerning to the lowest concentration, 3.1 μg DW mL−1, a loss of cell viability 
between 0% and 15% was observed for the aqueous and n-hexane extracts. Besides, it was also observed a 
slight stimulation of cell growth exposed to the aqueous extracts. At 3.1 μg DW mL−1 the methanolic 
extracts were the ones that induced the highest loss cell viability ranging from 8% to 50%. The one-way 
analysis (ANOVA) and Kruskal–Wallis statistical analysis revealed that n-hexane and methanol extracts 
are significantly different comparing with the control to p-value <0.05.  
 
  
The CC50 values determined to n-hexane and methanolic extracts are expressed in Table 4. The strongest 
cytotoxicity (<45 μg mL−1) was determined for methanolic extracts of LEGE 07073 and LEGE 07083 from 
the Chroococcales group and LEGE 06077 belonging to Nostocales group. 
 It was also observed that cytotoxicity in L929 cells increases in a dose and time dependent manner as 
shown to the three extracts with highest CC50 values in Fig. 1. The ANOVA analysis also revealed that values 
of three mentioned extracts are significantly different (p-value <0.05) for the series of concentrations 
used. 
 
The antiviral activity of CB extracts against influenza virus A, HSV-1, CVB3 and HRV-2 was determined 
by inhibition of viral cytopathic effect (CPE). With the exception of LEGE 07085, influenza virus, CVB3 
and HSV-1 showed CPE inhibition less than 20%, which is considered low antiviral activity. LEGE 07085 
showed anti-HSV-1 activity in GMK cells. The concentration required to reduce HSV-1 induced CPE by 
50% was 174.10 μg mL−1. No anti-HRV-2 activity was found. The same cell lines used to the antiviral 
activity assay were also used to evaluate cytotoxicity of the tested extracts. None of the extracts was 
cytotoxic in HeLa, MDCK, and GMK cells up to the maximum tested concentration of 200.00 μg mL−1 
(data not shown). 
4. Discussion 
Cyanobacteria are known to be a rich source of bioactive compounds and for producing toxins harmful to 
a diversity of organisms such as mammals, fishes, invertebrates and algae. Our data have shown that 
estuarine cyanobacterial isolates are putative candidates to induce DNA damage on bacteria (E. coli) 
without metabolic activation. Of a total of 18 crude methanolic (70% v/v) extracts, 5% had significant 
genotoxic effects. The genotoxic extract LEGE 06078 belongs to Phormidium genus (Oscillatoriales). In 
addition, 22% of the extracts, belonging to the Oscillatoriales and Nostocales families, were considered as 
potential genotoxic candidates because they have shown IF values higher than 1.5 at higher concentrations 
values (12.50 μg mL−1) but mostly without showing a dose-dependent response. Additionally, the absence 
of increased levels of alkaline phosphatase suggests that no in vivo cytotoxicity is observed. Nevertheless, 
decreased activity levels of this enzyme were observed in LEGE 07074 and 06077 extracts in a dose-
dependent manner, which can affect the galactosidase functioning. 
A study of Mankiewicz et al. (2002) had shown genotoxicity (without metabolic activation) by 
cyanobacterial extracts with the hepatotoxins microcystins. The IF values determined by Mankiewicz et al. 
(2002) range from 1.1 to 1.7 at 2 mg mL−1 which are slightly lower than the IF values of our data. Moreover, 
others studies with cyanobacteria, specifically benthic Phormidium strains from Baltic Sea, had shown the 
presence of apoptosis-inducing substances. Also, Shirahashi et al., 1993 and Teneva et al., 2005 and 
Surakka et al. (2005) had done a survey with freshwater Phormidium strains and showed that they are 
potential anti-tumour compounds producers. Nevertheless, the genus Phormidium of benthic estuarine 
cyanobacteria has far rarely been studied concerning toxin production and its potential effects on human 
and environmental health. Thus, our data are the first reporting genotoxicity induced by benthic 
Phormidium of estuarine ecosystems from temperate regions. 
The in vitro cytotoxicity tests are based on the concept that toxic chemicals or compounds can affect basic 
functions of cells which are common among all cells causing measurable cellular functional and structural 
damage. The choice of cell lines for in vitro cytotoxicity remains difficult as the type of cells available is 
very diverse (Bubik et al., 2008, Puerto et al., 2009, Surakka et al., 2005 and Takamatsu et al., 2004). 
Nevertheless, cytotoxicity evaluation with cell cultures allows a rapid, standardized and sensitive way to 
screen a large number of extracts for the presence of biologically harmful molecules. Regarding this, 
permanent cell lines are easy to maintain in culture and include a homogeneous cell population, being well 
suited for screening proposes due to the high reproducibility behaviour. 
The fibroblast cell line L929 is highly proliferative and is widely used in cytotoxicity testing, mainly 
regarding toxicity towards cellular viability and proliferation. Fibroblast cells are the most common cells 
of all types of connective tissues, being actively engaged in the synthesis and upkeep of the collagenous 
extracellular matrix, also modulating adjacent cell behaviour including migration, proliferation and 
differentiation. In this way, biological evaluation with fibroblast cell cultures might be regarded as general 
bioassay, providing reliable information concerning basal cytotoxicity (Freshney, 2000). Among the 54 
estuarine cyanobacteria extracts (hexane, methanol and water) tested, only hexane and methanol extracts 
impaired the viability of L929 fibroblasts. The cytotoxic effects were observed with methanolic and n-
hexane extracts in a dose- and time-dependent manner, being clear only for exposure times higher than 
24 h. The aqueous extracts did not affect the cell viability independently of the dose or exposure-time. The 
data obtained also point out that methanolic extracts have marked cytotoxic effects, with CC50 values that 
are slightly lower than those found with the hexane extracts. Members of all the three cyanobacterial orders 
studied had cytotoxic effects, although the lowest cytotoxic values were observed for Chroococcales and 
Nostocales. Surakka et al. (2005) had reported high cytotoxicity to human leukemia cells induced by 
Nostoc, Nodularia, Phormidium and Anabaena benthic strains from littoral habitats of Baltic Sea. Those 
genera excepting the Phormidium genus belong to the Nostocales family, supporting our findings. Our 
results showed that none of 18 isolates used in this study produce microcystins, nodularin or saxitoxin. So, 
we can infer that the observed cytotoxicity may be due to bioactive compounds present in the cyanobacterial 
extracts not previously described as known cyanotoxins. 
The 54 cyanobacterial extracts were also screened for antiviral activity. The aqueous extract, LEGE 07085, 
derived from Leptolyngbya isolate showed antiviral activity against HSV1 with an IC50 of 
174.10 μg mL−1with low or no toxic effects on GMK cells up to 200 μg mL−1. Several reports have been 
published about antiviral activity on cyanobacteria. The results were found for cyanobacteria from fresh 
and marine waters belonging mainly to Oscillatoriales and Nostocales orders. The antiviral effects observed 
were against HSV-1 and 2, influenza A and HIV viruses induced mostly by methanolic extracts \(Hayashi 
et al., 1996, Hernandez-Corona et al., 2002, Kanekiyo et al., 2007, Kanekiyo et al., 2005, Nowotny et al., 
1997, Ohta et al., 1998, Rechter et al., 2006 and Zainuddin et al., 2002). Nevertheless, Hayashi et al. (1996) 
reported anti-HSV activity (ED = 212 μg mL−1) of an aqueous extract of Nostoc in HeLa cell lines. In 
addition, the previous reports showed that the antiviral compounds and extracts belonged to the 
polysaccharide, carbohydrates and peptide groups. This might indicate that the compounds present in the 
cyanobacteria extracts may have highly polar moiety backing up the data now obtained. Furthermore, all 
the estuarine cyanobacteria extracts showed no long-term cytotoxicity to HeLa Ohio, MDCK and GMK 
cell lines at concentrations of up to 200 mg mL−1. Thus, the antiviral activity observed is induced by a 
potential virus-specific compound or mixture that has no effects on cellular metabolism. 
In addition, the MALDI-TOF analysis showed the presence of pheophorbide a and pheophytin a pigments 
as well as several peaks ranging from 600 to 1400 m/z ratio in the crude LEGE 07085 extract. Ohta et al. 
(1998) reported novel anti-HSV1 substances got from a marine green alga, Dunaliella primolecta, 
characterized as pheophorbide a like compounds. Thus, we assume that the potential anti-HSV-1 
compounds present on the aqueous LEGE 07085 extract may be a pheophorbide like compounds. This work 
reports that benthic and picoplanktonic estuarine cyanobacteria contain potentially genotoxic, cytotoxic and 
anti–herpes compounds. It will be important to study those extracts that had positive results with the battery 
of assays we used, specifically those compounds that inhibited the HSV1. 
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